One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 17,992 as of Tuesday, April 26, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,218 issues advancing vs. 684 declining with 156 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.1%. On the negative front, top decliners within the industry include Waters ( WAT), down 2.3%, and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.7%. Top gainers within the industry include Universal Health Services ( UHS), up 2.9%, WellCare Health Plans ( WCG), up 2.6%, Acadia Healthcare ( ACHC), up 2.6%, Laboratory Corp of America Holdings ( LH), up 0.9% and Aetna ( AET), up 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Parexel International ( PRXL) is one of the companies pushing the Health Services industry lower today. As of noon trading, Parexel International is down $1.82 (-2.7%) to $65.75 on average volume. Thus far, 247,336 shares of Parexel International exchanged hands as compared to its average daily volume of 501,400 shares. The stock has ranged in price between $65.00-$67.67 after having opened the day at $67.67 as compared to the previous trading day's close of $67.57.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. Parexel International has a market cap of $3.6 billion and is part of the health care sector. Shares are down 0.8% year-to-date as of the close of trading on Monday. Currently there are 7 analysts that rate Parexel International a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Parexel International Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, St Jude Medical ( STJ) is down $0.39 (-0.6%) to $60.16 on light volume. Thus far, 710,819 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $59.97-$60.72 after having opened the day at $60.66 as compared to the previous trading day's close of $60.55.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical has a market cap of $17.2 billion and is part of the health care sector. Shares are down 2.0% year-to-date as of the close of trading on Monday. Currently there are 12 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates St Jude Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and a generally disappointing performance in the stock itself. Get the full St Jude Medical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $5.70 (-0.9%) to $633.04 on light volume. Thus far, 137,054 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 379,100 shares. The stock has ranged in price between $631.62-$640.00 after having opened the day at $639.55 as compared to the previous trading day's close of $638.74.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $24.3 billion and is part of the health care sector. Shares are up 17.0% year-to-date as of the close of trading on Monday. Currently there are 11 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Intuitive Surgical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).